IP Library Granted Patent US 9,125,825
Granted Patent B2
US 9,125,825 · App. 12/763,632 · Granted Sep 8, 2015

Freeze-dried molded article containing magnesium ascorbyl phosphate

Inventor: Ralf Malessa (Essen, DE)
Assignee: Medskin Solutions Dr. Suwelack AG
A61K9/2095A23L1/00A61K8/676A61K8/733A61K9/0014A61K9/0056A61K36/82A61Q19/00A61K2800/84
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,125,825
App. No.
12/763,632
Granted
Sep 8, 2015
Kind
B2
Abstract

The invention relates to freeze-dried molded articles containing magnesium ascorbyl phosphate and alginate as well as optionally one or more active substances and/or auxiliary substances. Furthermore, the invention relates to methods for manufacturing these freeze-dried molded articles, the combination of such freeze-dried molded articles in kit-of-parts arrangements together with aqueous solutions, as well as the use of the freeze-dried molded articles and the kit-of-parts combinations for pharmaceutical and cosmetic application.

Claims (16)

1. A freeze-dried molded article comprising:

(a) 10-25 wt-% magnesium ascorbyl phosphate;

(b) 25-80 wt-% of a pharmaceutical or cosmetic oil selected from the group consisting of jojoba oil, squalene oil, caprylic/capric acid tryglycerides, and mixtures thereof; and

(c) 20-40 wt-% calcium-free sodium alginate;

wherein the molded article decomposes completely without mechanical influence within ≦30 seconds when added to water, and wherein the freeze-dried molded article does not comprise a maleic acid copolymer.

2. The freeze-dried molded article according to claim 1 , further comprising one or more active substances.

3. The freeze-dried molded article according to claim 2 , wherein at least one of the one or more pharmaceutically or cosmetically active substances is selected from the group consisting of vitamins and their derivatives.

4. The freeze-dried molded article according to claim 3 , wherein the pharmaceutically or cosmetically active substance is selected from the group consisting of vitamin C (ascorbic acid) and its derivatives.

5. The freeze-dried molded article according to claim 2 , wherein the one or more pharmaceutically or cosmetically active substances is selected from the group consisting of vitamin C (ascorbic acid) and its derivatives.

6. The freeze-dried molded article according to claim 1 , whose 1% by wt, solution or suspension in water, at 20° C., has a pH value ≧4.0.

7. The freeze-dried molded article according to claim 6 , whose 1% by wt, solution or suspension in water, at 20° C., has a pH value ≧5.0.

8. The freeze-dried molded article according to claim 7 , whose 1% by wt. solution or suspension in water, at 20° C., has a pH value ≧6.0.

9. The freeze-dried molded article according to claim 1 , which decomposes completely within ≦20 seconds when water is added.

10. The freeze-dried molded article according to claim 9 , which decomposes completely within ≦10 seconds when water is added.

11. The freeze-dried molded article according to claim 10 , which decomposes completely within ≦5 seconds when water is added.

12. The freeze-dried molded article according to claim 1 , wherein the molded article contains ≧20% by wt. magnesium ascorhyl phosphate, based on the total weight of the freeze-dried molded article.

Assignments (2)
CHANGE OF NAME Recorded May 6, 2013
From: DR. SUWELACK SKIN & HEALTH CARE AG
To: MEDSKIN SOLUTIONS DR. SUWELACK AG
Reel/Frame 030359/0512 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2010
From: MALESSA, RALF
To: DR. SUWELACK SKIN & HEALTH CARE AG
Reel/Frame 024632/0555 →
Priority Claims (1)
EP 09158475 · Apr 22, 2009 · regional
Continuity (1)
Related Publication 20100272834A1 · Oct 28, 2010